Vaccinated patients were less likely to be treated with remdesivir, which at our institution is not administered to outpatients, as they were less likely to require hospital admission (unvaccinated vs 2 vs ≥3 doses: 50% vs 19% vs 17%; P = .008); this difference did not reach statistical significance among hospitalized patients, where remdesivir is administered to most OTRs, especially those requiring supplemental O 2 (unvaccinated vs 2 vs ≥3 doses: 89% vs 50% vs 63%) ( Table 1 ).
← all excerpts
mRNA Vaccination Decreases COVID-19-Associated Morbidity and Mortality Among Organ Transplant Recipients: A Contemporary Cohort Study.
1
—
—